Clinical and Translational Hereditary Cancer Program

Researchers on the NCI Moonshot grant focused on hereditary cancers include (front row, from left) Natasha Celaya-Cobbs, LPN, Georgia Wiesner, MD, Sarah Bland, MPH, MBA, (back row, from left) Trent Rosenbloom, MD, Josh Peterson, MD, MPH, and Marc Beller, PMP, BA.
November 14, 2019

NCI ‘Moonshot’ grant to boost hereditary cancer identification

VUMC is leading an initiative to establish a streamlined process for collection of family health histories that could set the stage for a standardized system to make the information easily accessible.

By Tom Wilemon
November 8, 2016

My Southern Health: What to know about genetic testing and personalized medicine

Personalized medicine is about tailoring treatment to individual patients based on their genetics. Georgia L. Wiesner, director of the Vanderbilt-Ingram Cancer Center’s Clinical and Translational Hereditary Cancer Program, explains the “4 Ps” of personalized medicine and the benefits it offers.

By VUMC News and Communications